Parkinson’s disease is one of the most common neurodegenerative disorders in the world, affecting millions of people. It primarily manifests with motor symptoms such as tremors, rigidity, and slowness of movement, but can also include non-motor symptoms like depression, cognitive problems, and sleep disturbances. Parkinson’s is a progressive disease, meaning that symptoms tend to worsen over time.
However, one of the most frequently asked questions by patients and their families is: “Is it possible to slow down the progression of Parkinson’s?” While there is currently no definitive cure, there are promising strategies aimed at slowing its progression. These include lifestyle changes, pharmacological therapies, and innovative approaches such as peripheral mechanical stimulation.
In this article, we will explore the options available to slow down the progression of Parkinson’s disease and improve patients’ quality of life.
What is Parkinson’s disease?
Parkinson’s is a central nervous system disorder caused by the degeneration of neurons that produce dopamine, an essential neurotransmitter for movement control. The lack of dopamine leads to a series of motor symptoms, including tremors, muscle rigidity, slowness of movement (bradykinesia), and postural instability.
Although the precise causes of Parkinson’s are still unknown, a combination of genetic and environmental factors appears to contribute to the onset of the disease. While some individuals may inherit a genetic predisposition, most cases are idiopathic, meaning they have no identifiable cause.
In recent years, research has made significant progress in understanding the disease, paving the way for the development of more effective treatments.
Pharmacological treatments: what options are available today?
The treatment of Parkinson’s disease primarily focuses on managing symptoms through medications that increase dopamine levels in the brain or enhance its effectiveness. The most commonly used drug is levodopa, a precursor of dopamine that is converted into dopamine once it reaches the brain. Levodopa is effective in reducing motor symptoms, but over time it may lose some of its effectiveness, leading to fluctuations in symptoms. To compensate, the dosage of the drug is often increased, which, in the long term, can cause involuntary movements known as dyskinesias.
In addition to levodopa, there are other classes of drugs used to treat Parkinson’s, including dopamine agonists and MAO-B inhibitors, which slow down the breakdown of dopamine. However, a rapidly growing area of research is that of neuroprotective drugs, or therapies that not only alleviate symptoms but may protect neurons from degeneration and potentially slow the progression of the disease. Although no neuroprotective drug has yet been definitively approved, some preliminary studies on drugs like rasagiline (an MAO-B inhibitor) and dopamine agonists have shown promising results.
The importance of physical exercise in managing Parkinson’s
One of the most effective non-pharmacological interventions for patients with Parkinson’s is physical exercise. Several scientific studies have shown that regular physical activity can improve motor function, reduce non-motor symptoms, and enhance patients’ quality of life. What makes exercise particularly interesting is its effect on neuroplasticity, the brain’s ability to adapt and reorganize itself. Physical exercise stimulates the release of neurotrophic factors, such as BDNF (Brain-Derived Neurotrophic Factor), which promote the survival and growth of neurons. This could have a protective effect on the brain and, therefore, potentially slow the progression of the disease.
Studies by Wittenberg (2009) and Reid et al. (2015) have demonstrated how neuroplasticity can be activated through physical exercise, improving motor response and promoting brain adaptation. Physical exercise does not have to be intensive but rather targeted and consistent. Recommended activities include balance, flexibility, and resistance exercises, such as tai chi, Pilates, yoga, walking, and swimming, which help improve coordination and posture, reducing the risk of falls, a common problem in patients with Parkinson’s.
Nutrition and Parkinson’s: the role of diet
Diet also plays an important role in managing Parkinson’s disease. While there is no specific diet to prevent or cure Parkinson’s, a balanced diet rich in nutrients can help maintain brain health and reduce oxidative stress, which is one of the factors that may contribute to neuronal degeneration.
Diets rich in antioxidants, such as fruits and vegetables, can help combat free radicals and help reduce oxidative stress in the brain. Omega-3 fatty acids, found in fatty fish, for example, have shown beneficial effects on the brain; they can reduce inflammation and protect neurons.
Another aspect to consider is constipation, a common problem in patients with Parkinson’s. A diet rich in fiber, combined with good hydration, can alleviate this symptom, improving overall well-being.
Physical therapy and speech therapy: essential supports for quality of life
Physical therapy is a key element in helping patients with Parkinson’s maintain mobility, reduce the risk of falls, and improve their quality of life. Physical therapists can develop targeted exercise programs to improve balance, muscle strength, and flexibility. These programs, personalized for each patient, help maintain a good level of physical functionality, enhancing patients’ independence.
Speech therapy also plays a crucial role, especially for patients who develop speech or swallowing difficulties, two problems that often emerge as the disease progresses. Through specific exercises, speech therapists can help patients improve speech clarity and manage swallowing problems, preventing complications such as aspiration during meals.
Complementary therapies: an integrated approach
Many patients turn to complementary therapies to manage Parkinson’s symptoms and thus improve their quality of life. These include acupuncture, meditation, music therapy, deep brain stimulation (DBS), and AMPS therapy. Although the effectiveness of some of these therapies is still under study, many people report benefits, especially in terms of stress reduction and improved emotional well-being.
Deep brain stimulation, in particular, is a surgical procedure that involves implanting electrodes in the brain to regulate neuronal activity. This technique has been successfully used in some patients to reduce motor symptoms, especially in those who no longer respond well to medications. However, it is an invasive procedure and not suitable for all patients.
Gondola AMPS therapy: an innovative approach
One of the most innovative complementary therapies in the treatment of Parkinson’s is Gondola AMPS (Automated Mechanical Peripheral Stimulation). This therapy is based on the mechanical stimulation of specific points on the soles of the feet, through which an impulse is sent to the brain that can help increase functional connectivity in brain areas involved in movement.
The automated mechanical stimulation is delivered through a medical device called Gondola, which applies controlled pressure to four points on the feet. This stimulation has been effective in increasing the length, stability, and speed of gait, improving walking, balance, and reducing the risk of falls.
Clinical studies, such as those by Pagnussat et al. and Quattrocchi et al., have shown that Gondola AMPS therapy not only improves gait parameters but also stimulates brain neuroplasticity, enhancing connectivity between motor circuits.
In addition to being used in combination with other therapies, such as pharmacology and physical therapy, improving the overall quality of life of patients, this treatment is non-invasive, making it a safe and well-tolerated option, reducing the risks associated with surgical procedures or more invasive interventions.
Although Gondola AMPS therapy is still under study, it represents one of the new frontiers in the treatment of Parkinson’s disease, offering hope to patients seeking non-invasive solutions to manage motor symptoms.
Future perspectives: Parkinson’s research
The future of Parkinson’s treatment could hold exciting surprises. Current research is focusing on several promising areas, such as the use of stem cells to regenerate damaged neurons, gene therapy to correct the genetic defects associated with the disease, and the development of new neuroprotective drugs.
Another area of great interest is that of neuroinflammation, or inflammation of the central nervous system. Reducing inflammation could represent an effective strategy to slow the progression of the disease.
Furthermore, the identification of early biomarkers of Parkinson’s could allow for earlier diagnosis and targeted interventions before motor symptoms become evident.
Slowing the progression of Parkinson’s disease is a complex challenge, but not impossible. While there is still no definitive cure, advances in research, combined with lifestyle changes, physical exercise, and innovative therapies like Gondola AMPS therapy, offer new hope for improving patients’ quality of life.
The key to effective Parkinson’s management lies in a personalized approach that integrates medications, physical therapies, medical devices, and targeted rehabilitation strategies.
References:
- Stocchi F, Sale P, Kleiner AF, et al. Long-term effects of automated mechanical peripheral stimulation on gait patterns of patients with Parkinson’s disease. Int J Rehabil Res. 2015;38(3):238-245.
- Barbic F, Galli M, Dalla Vecchia L, et al. Effects of mechanical stimulation of the feet on gait and cardiovascular autonomic control in Parkinson’s disease. J Appl Physiol (1985). 2014;116(5):495-503.
- Galli M, Kleiner A, Gaglione M, et al. Timed Up and Go test and wearable inertial sensor: a new combining tool to assess change in subject with Parkinson’s disease after automated mechanical peripheral stimulation treatment. Int J Eng Innov Technol. 2015;4(11):155-163
- Galli M, Vicidomini C, Rozin Kleiner AF, et al. Peripheral neurostimulation breaks the shuffling steps patterns in Parkinsonian gait: a double blind randomized longitudinal study with automated mechanical peripheral stimulation. Eur J Phys Rehabil Med. 2018;54(6):860-865.
- Kleiner A, Galli M, Gaglione M, et al. The Parkinsonian Gait Spatiotemporal Parameters Quantified by a Single Inertial Sensor before and after Automated Mechanical Peripheral Stimulation Treatment. Parkinsons Dis. 2015;2015:390512.
- Kleiner AFR, Souza Pagnussat A, Pinto C, Redivo Marchese R, Salazar AP, Galli M. Automated Mechanical Peripheral Stimulation Effects on Gait Variability in Individuals With Parkinson Disease and Freezing of Gait: A Double-Blind, Randomized Controlled Trial. Arch Phys Med Rehabil. 2018;99(12):2420-2429.
- Pagnussat AS, Kleiner AFR, Rieder CRM, et al. Plantar stimulation in parkinsonians: From biomarkers to mobility – randomized-controlled trial. Restor Neurol Neurosci. 2018;36(2):195-205.
- Pagnussat AS, Salazar AP, Pinto C, et al. Plantar stimulation alters brain connectivity in idiopathic Parkinson’s disease. Acta Neurol Scand. 2020;142(3):229-238.
- Pinto C, Pagnussat AS, Rozin Kleiner AF, et al. Automated Mechanical Peripheral Stimulation Improves Gait Parameters in Subjects With Parkinson Disease and Freezing of Gait: A Randomized Clinical Trial. Am J Phys Med Rehabil. 2018;97(6):383-389.
- Prusch JS, Kleiner AFR, Salazar AP, et al. Automated mechanical peripheral stimulation and postural control in subjects with Parkinson’s disease and freezing of gait: a randomized controlled trial. Funct Neurol. 2018;33(4):206-212.
- Quattrocchi CC, de Pandis MF, Piervincenzi C, et al. Acute Modulation of Brain Connectivity in Parkinson Disease after Automatic Mechanical Peripheral Stimulation: A Pilot Study. PLoS One. 2015;10(10):e0137977. Published 2015 Oct 15.
- Zamuner AR, Shiffer D, Barbic F, et al. Mechanical somatosensory stimulation decreases blood pressure in patients with Parkinson’s disease. J Hypertens. 2019;37(8):1714-1721.
- Tedeschi M, Rinaldo V, Galli M, et al. Automated mechanical peripheral stimulation for gait rehabilitation in Parkinson’s disease: A comprehensive review. Clin Park Relat Disord. 2023;8:100208.
- Wittenberg GF. Neural plasticity and treatment across the lifespan for motor deficits in cerebral palsy. Dev Med Child Neurol. 2009;51 Suppl 4:130-133.
- Reid LB, Rose SE, Boyd RN. Rehabilitation and neuroplasticity in children with unilateral cerebral palsy. Nat Rev Neurol. 2015;11(7):390-400.
